Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Hyperfractionated cyclophosphamide, bortezomib and dexamethasone for initial treatment of newly diagnosed multiple myeloma with renal dysfunction

Guneet Kaleka, Paul Kaesberg, Brian Jonas, Naseem Esteghamat, Joseph Tuscano, Aaron Rosenberg

Blood (2025) 146 (Supplement 1): 4057.

https://doi.org/10.1182/blood-2025-4057

Published: 2025

Journal Articles

A Phase II Study of Brentuximab Vedotin and Bendamustine for Relapsed/Refractory Follicular Lymphoma

Guneet Kaleka, Benjamin Moskoff, Aneeqa Zafar, Naseem S. Esteghamat, Mehrdad Abedi, Francisco Andres Socola, Rasmus T. Hoeg, Joseph M Tuscano

Blood (2024) 144 (Supplement 1): 6318.

https://doi.org/10.1182/blood-2024-210372

Published: 2024

Journal Articles

Real World Outcomes of Patients with Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation after Induction with Liposomal Daunorubicin-Cytarabine (CPX-351)

Guneet Kaleka, Dat Ngo, Dongyun Yang, Sally Mokhtari, Guido Marcucci, Ryotaro Nakamura, Vinod Pullarkat, Caspian H. Oliai, Amandeep Salhotra

Blood (2023) 142 (Supplement 1): 5938.

https://doi.org/10.1182/blood-2023-183053

Published: 2023

Journal Articles

The Trend of Respiratory Virus Infection in Allogeneic Bone Marrow Transplant Recipients during the COVID Pandemic

Guneet Kaleka, John Sharp, Kailyn Kim, Pryce Gaynor, Gary J. Schiller, Wanxing Chai-Ho

Blood (2022) 140 (Supplement 1): 5096–5097.

https://doi.org/10.1182/blood-2022-167773

Published: 2022

Journal Articles

Outpatient Vyxeos Induction without Planned Admission for Select Patients with Secondary Acute Myeloid Leukemia (sAML): A Multicenter Analysis of Safety and Healthcare Resource Utilization

Gina Keiffer, Guneet Kaleka, Caspian Oliai, Lindsay Wilde, Neil Palmisiano, Margaret Kasner

Blood (2022) 140 (Supplement 1): 3320–3321.

https://doi.org/10.1182/blood-2022-170710

Published: 2022

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Hyperfractionated cyclophosphamide, bortezomib and dexamethasone for initial treatment of newly diagnosed multiple myeloma with renal dysfunction

A Phase II Study of Brentuximab Vedotin and Bendamustine for Relapsed/Refractory Follicular Lymphoma

Real World Outcomes of Patients with Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation after Induction with Liposomal Daunorubicin-Cytarabine (CPX-351)

The Trend of Respiratory Virus Infection in Allogeneic Bone Marrow Transplant Recipients during the COVID Pandemic

Outpatient Vyxeos Induction without Planned Admission for Select Patients with Secondary Acute Myeloid Leukemia (sAML): A Multicenter Analysis of Safety and Healthcare Resource Utilization

Email alerts

ASH Publications

American Society of Hematology

Update search

Hyperfractionated cyclophosphamide, bortezomib and dexamethasone for initial treatment of newly diagnosed multiple myeloma with renal dysfunction

A Phase II Study of Brentuximab Vedotin and Bendamustine for Relapsed/Refractory Follicular Lymphoma

Real World Outcomes of Patients with Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation after Induction with Liposomal Daunorubicin-Cytarabine (CPX-351)

The Trend of Respiratory Virus Infection in Allogeneic Bone Marrow Transplant Recipients during the COVID Pandemic

Outpatient Vyxeos Induction without Planned Admission for Select Patients with Secondary Acute Myeloid Leukemia (sAML): A Multicenter Analysis of Safety and Healthcare Resource Utilization

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only